Affy Registers Uptick in Q2 Revenue, Narrowed Loss

Jul 25, 2002

SAN FRANCISCO, July 25 - Affymetrix yesterday reported a bump up in revenue, decreased losses, and a slight increase in R&D for the second quarter.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.